← Open Payments lookup

MIA TRUPIANO: Open Payments

NPI 1053697599 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$670 in 32 payments from 10 companies in 2025. Trend: 2023 $97 · 2024 $309 · 2025 $670

Food & beverage: $670
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)16$318
E.R. Squibb & Sons, L.L.C.3$62
Otsuka America Pharmaceutical, Inc.2$60
Vanda Pharmaceuticals Inc.3$54
Indivior Inc.1$36
Braeburn Inc.2$33
Teva Pharmaceuticals USA, Inc.2$33
Neurocrine BioSciences, Inc.1$32
Axsome Therapeutics, Inc.1$23
Exact Sciences Corporation1$20

Products named: CAPLYTA, COBENFY, REXULTI, FANAPT, SUBLOCADE, BRIXADI, AUSTEDO XR, INGREZZA.

Industry payments across LA — which companies pay providers there.